Bitget App
Trade smarter
MarketsTradeFuturesEarnSquareMore
Correction to Moderna Shares and mRNA Cancer Vaccine Article -- WSJ

Correction to Moderna Shares and mRNA Cancer Vaccine Article -- WSJ

Dow JonesDow Jones2026/08/19 20:48

Merck's blockbuster drug is named Keytruda. "Moderna Shares More Than Double on Success of mRNA Cancer Vaccine," at 6:45 a.m. ET , incorrectly called it Ketruda, in one instance.

(END) Dow Jones Newswires

August 19, 2026 16:48 ET (20:48 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.